Category: Specific Treatments

Specific Treatments

5-ASA

Mesalamine

Steroids

Budesonide

Infliximab

Remicade

Adalimumab

Humira

Thiopurines

Imuran, 6-MP

Vedolizumab

Entyvio

Ustekinumab

Stelara

Tofacitinib

Xeljanz

Email Newsletter

Recent News

Childhood-onset IBD leads to shorter adult height
March 17, 2020
Adalimumab trials show low rate of IBD adverse events
March 16, 2020
Highlights from IBD Horizons
March 16, 2020
Crohn’s and Colitis Foundation issues guidance on COVID-19 for patients with IBD
March 13, 2020
Healthy lifestyle linked with reduced mortality in IBD
March 11, 2020
Anti-IL-23 therapy effective in treating IBD
March 9, 2020
IBD treatment algorithm should optimized, personalized for patients
March 9, 2020
CMHP recommends approval of Entyvio for ulcerative colitis, Crohn’s disease
March 7, 2020
Frailty linked with increased infection risk after immunosuppression for IBD
March 3, 2020
IBD treatment plan ‘needs to be a continuous conversation’
February 25, 2020